*Correspondence: Lili Zhou, [email protected] These authors have contributed equally to this work This article was submitted to Renal Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Zoico 2004
BPC-157 works by activating pathways your body uses to repair itself: increasing blood flow, reducing inflammation, and stimulating the production of collagen and growth factors that rebuild damaged tissue
It incorporates key modifications, including 14E/17R mutations to stabilize an -helical segment via a salt bridge, multiple proline substitutions (25P, 28P, 29P) to reduce -sheet formation, and N-terminal C20 fatty diacid lipidation for reversible albumin binding (Kruse et al
Injury and death of VSMCs are thought to contribute substantially to the pathological microenvironment within the false lumen [65]
doi: 10.1111/plb.13030 41 KnstlerA.KirlyL.KtayG.EnyediA